CHAPTERS
- 0:01 – 1:22
Space is becoming a practical biotech & pharma platform
The video opens by reframing space from science fiction into an emerging R&D and manufacturing environment for life sciences. Falling launch costs and the next phase of commercial space stations are positioned as catalysts for broader participation.
- •Space is presented as a near-term opportunity for biotech and pharma
- •Launch costs are dropping dramatically (Falcon 9 today; Starship potential)
- •2030+ outlook: people spending longer durations in orbit via commercial stations
- •Space should be viewed as a laboratory with a repeatable logistics path
- •Microgravity can enable unique drug development and manufacturing possibilities
- 1:22 – 2:00
Boryung’s mission: treating space as the next frontier for healthcare growth
Jack Lim introduces Boryung and compares the current moment to an age of discovery—expanding beyond Earth as the new boundary. The company frames space as both a business growth engine and a way to support human exploration.
- •Jack Lim introduces his role and Boryung’s identity as a pharma company
- •Analogy to historical exploration and new frontiers
- •Space is framed as a new growth opportunity for healthcare companies
- •Goal includes enabling safer human exploration through health solutions
- 2:00 – 2:21
Inspiration and the case for preparing for human spaceflight
The narrative shifts to the inspirational pull of space and the practical need to keep people safe as access expands. This sets the rationale for building a broader space-health ecosystem.
- •Quote: “Rockets run on fuel; NASA runs on inspiration”
- •Inspiration draws more people and organizations into space
- •Safety and readiness become urgent as human spaceflight grows
- •Positions Korea’s space efforts within this momentum
- 2:21 – 2:51
Humans in Space Challenge: an open-innovation pipeline for space health
Boryung’s Humans in Space Challenge is introduced as a global open innovation program to find startups and researchers working on biomedical and healthcare problems in space. The program emerged from an early uncertainty about where to start and a push to gather global expertise.
- •Global challenge program focused on biomedical/space healthcare
- •Targets both startups offering services and researchers wanting to fly experiments
- •Early-stage challenge: not knowing where to begin
- •Approach: reach out to experts worldwide to frame actionable problems
- 2:51 – 3:21
Defining two problem areas: astronaut health risks vs. Earth benefits from microgravity
With guidance from an ex-NASA astronaut/Georgia Tech professor, the program narrows into two scopes. One targets critical healthcare problems for astronauts; the other uses microgravity to address major Earth health issues like cancer and aging.
- •Two scopes: “critical problems in space” and “critical problems on Earth”
- •Astronaut health risks expected to rise with longer missions
- •Microgravity seen as a tool to unlock breakthroughs for diseases on Earth
- •Program structure designed to pursue both scopes in parallel
- 3:21 – 4:52
Partnering with NASA HRP and top universities—because even NASA has unsolved problems
Lim explains how connecting with NASA’s Human Research Program validated the problem space and revealed major gaps in knowledge—especially for long-duration missions like Mars. This opened the door for commercial players to contribute with more flexibility and faster iteration, expanding partnerships to leading universities.
- •Engagement with NASA HRP aligned with similar research priorities
- •Human risk differs across LEO, lunar missions, and Mars missions
- •Mars transit (~6 months) introduces complex health challenges
- •If NASA doesn’t have all answers, commercial innovation can add value
- •Partnerships expand (NASA as judge; then Stanford/MIT/Harvard links)
- 4:52 – 5:22
From research testbed to manufacturing: why microgravity attracts companies
Space is positioned not only as a place to test hypotheses, but also as an emerging manufacturing environment. The chapter highlights companies pursuing microgravity-enabled production, signaling a shift from experimentation to scalable applications.
- •Space used as both R&D testbed and potential manufacturing platform
- •Microgravity can change material and biological processes
- •Example spotlight: LambdaVision’s artificial retina development
- •Program gains traction partly because few have run similar initiatives
- 5:22 – 6:03
Startup case study: LambdaVision’s win and what changed in microgravity
A participant describes pitching in the challenge, winning, and using support to run additional microgravity research. Results suggested a more even, stable product—showing why space experiments can materially improve outcomes even with constrained payload formats.
- •LambdaVision participates and wins the 2023 challenge
- •Pitch competition and exposure to a large audience
- •Funding/support enables additional microgravity research
- •Microgravity results: improved uniformity and stability
- •Constraint example: experiments must be enclosed (shoebox-sized payload)
- 6:03 – 6:33
Lowering barriers for startups: mapping prototypes to space and matching partners
The program emphasizes that many startups don’t naturally consider space as an extension of their existing tech. Boryung positions itself as the connector—helping teams adapt experiments for flight and find the right partners and platforms.
- •Many startups haven’t considered adapting existing prototypes for space
- •Space framed as a “next opportunity” for long-term growth
- •Boryung’s role: connect teams to partners and appropriate platforms
- •Focus on enabling real deployments, not just ideas
- 6:33 – 7:03
Funding and selection model: equity investment plus ‘orbital launch funding’
Lim outlines how the challenge evaluates applicants and supports them financially. The model combines small equity checks with coverage of launch costs, while leveraging judges, agencies, and venture partners to accelerate credible pathways to orbit.
- •Structured judging and review process for applicants
- •Two support tracks: equity stake investment and launch-cost coverage
- •“Orbital launch funding” covers specific experimentation launch costs
- •VC partners evaluate equity-track companies as investments
- •Leverages relationships with NASA/ESA and other agencies
- 7:03 – 8:09
Building an accelerator and ecosystem despite not being a traditional space company
Boryung describes its internal Humans in Space Accelerator Program and its ambition to build the “blueprint” for the next 10–20 years. The focus is on ecosystem design—connecting research, infrastructure, and stakeholders to create repeatable pathways for space healthcare.
- •Internal accelerator program extends support beyond the challenge
- •Boryung positions itself as a platform-builder and connector
- •Long-term ecosystem planning: what the industry needs in 5–10+ years
- •Acknowledges difficulty and uncertainty of pioneering work
- •Growth requires movement; stagnation limits progress
- 8:09 – 8:54
The real bottleneck: fragmented innovation and missing connections
Lim reflects on a key insight—researchers and startups are working on valuable, diverse problems but remain scattered and disconnected. Boryung aims to use its network across universities and agencies to align complementary efforts and increase success rates.
- •Space-health innovation is fragmented across many teams
- •High value exists, but teams often lack the right partners
- •Boryung leverages networks across prestigious universities and agencies
- •Goal: connect similar experiments and complementary expertise
- 8:54 – 9:25
Community and collaboration: why challenges accelerate bold progress
A participant perspective highlights the energizing effect of meeting other entrepreneurs and thought leaders. The chapter stresses that visionary goals in space require collective effort, ongoing idea sharing, and a strong network to sustain momentum.
- •Challenges create dense networks of founders, researchers, and leaders
- •Bold, visionary projects require cross-team collaboration
- •Ongoing idea sharing continues beyond the event
- •Entrepreneurial energy helps sustain long development cycles
- 9:25 – 11:30
Call to action: take risks and broaden who ‘belongs’ in the space economy
The closing message argues that space is complex but not new—and that the infrastructure foundations (ISS era) show what’s possible when ecosystems form. Viewers are urged to be bold, recognize that space opportunities span far beyond engineering, and consider adapting existing business models to microgravity-enabled markets.
- •Space healthcare ecosystem builds on decades of ISS-era precedent
- •Boryung claims unique value in operationalizing this ecosystem approach
- •Advice: take risks, be bold, and stay adaptable
- •Space opportunities extend beyond scientists/engineers (insurance, hospitality, textiles, etc.)
- •Encouragement to test/apply existing technologies and business models in space
